oxidation ratio and glutathione elevated compared with controls (p < 0.0001). Conclusions Although no clinical differences between CTRL and DEF pups were observed at GD56, the present data suggest that vitC plays a role in early fetal development. Although no clinical differences between CTRL and DEF pups were observed at GD56, the present data suggest that vitC plays a role in early fetal development. Low maternal vitC intake during pregnancy may compromise maternal weight gain, placental function and intrauterine development.
Introduction
During normal prenatal development, fetal vitamin C (vitC) concentrations in plasma are higher than maternal levels, suggesting that high vitC status is of particular importance in the fetus [1] [2] [3] [4] [5] . We recently reported that preferential fetal vitC transport across the placenta may be overridden during prolonged maternal vitC deficiency, providing the mother with a basal vitC supply at the expense of the fetus and possibly interfering with prenatal development [6] . Moreover, experimental data by us and others have shown that a chronic, non-scorbutic maternal vitC deficiency may result in increased oxidative stress, reduced birth weight and impaired brain development in offspring [7] [8] [9] [10] [11] . These findings question the general assumption that a fetus is protected from vitC deficiency by maternal supply regardless of maternal vitC status. However, the potential impact of maternal vitC deficiency on fetal vitC status and development, and placental vitC concentration and regulation is currently elusive.
In most mammals, the fetus is dependent on maternal vitC supply until late gestation where endogenous vitC synthesis begins [12] . However, due to a non-functional gene encoding for l-gulonolactone oxidase-the enzyme required to catalyze the final step in the conversion of glucose to ascorbate-humans and a few other mammals including guinea pigs rely consistently on an adequate dietary intake [13] . In healthy non-pregnant women, tissue saturation will be achieved by a daily intake of about 400 mg vitC resulting in plasma concentration about 70 µM, after which excess amounts will be excreted in the urine [14, 15] . This can be achieved by daily ingestion of 5-8 servings of fruit [16] ; however, large population surveys report that up to 75 % receive a vitC and fruit intake below recommendations [17, 18] . Several reports have shown vitC deficiency (defined as a plasma concentration <23 µM) or even severe vitC deficiency (<11 µM) in up to 30 % of pregnant women and their children in Western populations [3, 19, 20] .
Vitamin C has an essential function in multiple biological processes and is differentially distributed to target organs [21] . Transport to specific tissues is achieved primarily through active, sodium-dependent transporters (SVCT1 and SVCT2) [22, 23] . The SVCT1 is a low-affinity/high-capacity transporter and is localized to epithelia, e.g., in the gastro-intestinal channel and kidney [22] . In contrast, the SVCT2 is a high-affinity/low-capacity transporter and can be found in most tissues [24] . Mice-pups devoid of the SVCT2 transporter display very low vitC concentrations and die immediately after birth demonstrating that SVCT2-mediated vitC transport is essential to perinatal survival [25, 26] . Both SVCTs have been identified in the human placenta [27] , and maternal vitC deficiency has been associated with decreased fetal and placental growth [28] as well as an increased risk of preterm delivery and low birth weight [5, 29, 30] . Likewise, pregnant women with low plasma ascorbate has been reported to have an increased risk of preeclampsia and preterm delivery compared with sufficient counterparts suggesting a positive effect of supplementation [28] . The potential benefit of supplementation during pregnancy is, however, debatable and has yet to be confirmed in larger randomized controlled trials (RCTs) [31] [32] [33] .
Besides modeling humans with regard to a dietary vitC requirement [34] [35] [36] [37] , the guinea pig is, next to primates, the laboratory animal sharing most similarities with human placentation and prenatal development [38] [39] [40] [41] . Hence, it is a suitable model for studying the effects of dietary imposed maternal vitC deficiency and placental transfer. Using the guinea pig as in vivo experimental model, the present study investigated the impact of prolonged maternal vitC deficiency on maternal, fetal and placental weight parameters and fetal and placental vitC status at two different gestational stages during the second half of gestation covering the period of extensive prenatal growth [42] . In a controlled design, this study targets differences in the materno-fetal vitC transfer and separates effect of developmental stage opposed to effects of vitC status, hereby assessing potential increased sensitivity between the investigated stages of gestation. Gestational day (GD) 45 was considered to be the first gestational stage at which a sufficient fetal blood sample for biochemical analyses could be obtained. GD56 was selected as the latest time point before spontaneous delivery, considering the normal gestational span from GD58 to GD73 in guinea pigs [43] .
The study adds novel information to the effects of maternal nutrition on pregnancy outcome, defining specific consequences of vitC deficiency in a natural animal model. Should our findings translate to humans, the reported effects may contribute to the assessment of vitC supplementation during pregnancy to high-risk individuals.
Materials and methods

In vivo study
This study was conducted following protocol approval by the Danish Animal Experimental Inspectorate under the Ministry of Food, Agriculture and Fisheries. Analytical data from a subset of animals have previously been published [10] . Upon arrival at GD6-10, twenty time-mated second-time breeding Dunkin Hartley guinea pig dams (Charles River Laboratories, Kisslegg, Germany) were tagged subcutaneously in the neck with a microchip for identification (PET-CHIP ID, Danworth Farm, West Sussex, UK). The animals were randomized into four groups (n = 4/5), stratified for weight and gestational day (GD provided for each animal by Charles River Laboratories) and allocated to receive either sufficient (918 mg/kg by analysis) or deficient (titrated to 100 mg/kg by mixing 918 mg vitC/kg with 0 mg VitC/kg feed) quantities of vitC in the diet. Dams were also designated to receive planned cesarean section (followed by euthanasia) at either GD45 or GD56 (CTRL45, CTRL56, DEF45 and DEF56).
The diets were identical in all aspects except vitC content and designed to meet all nutritional requirements of pregnant guinea pigs (SSNIFF Spezialdiäten GmbH, Soest, Germany). A vitC content of 100 mg/kg has previously been shown by us to induce a non-scorbutic vitC deficiency in pregnant guinea pigs [6] . Accordingly, none of the animals exhibited any clinical signs of scurvy during the study period. CTRL and DEF animals were group-housed in identical floor pens and allowed free access to food pellets, dried hay (devoid of vitC by analysis) and drinking water. Recordings of food and water intake were not performed due to the applied housing conditions. The temperature was kept constantly between 20 and 23 °C and a 12:12-hour dark/light cycle was maintained.
As part of general monitoring of the animals, dams were weighed weekly and blood was collected upon arrival and subsequently every second week to confirm response to dietary vitC regimen. Blood sampling was carried out in the morning from the saphenous vein as described previously [6] . Prior to every blood sampling (except directly upon arrival), animals were 'vitC-fasted,' i.e., offered the identical diet without vitC (0 mg/kg feed) for 12 h prior to sampling. This served to limit variation induced by differences in recent intake of vitC from the provided feed, and at the same time avoiding absolute fasting, which is not well tolerated by guinea pigs. We have found that this 'vitC-fasted' measure reflects a 'plasma steady-state level' better than what may be highly fluctuating peak values obtained from non-fasted animals (data not shown). Three animals were not pregnant and were excluded from the study leaving n = 4 in three groups (Table 1) . Necropsy revealed no macroscopic signs of disease or interrupted pregnancy, and the animals were therefore concluded not to have conceived.
Euthanasia
As part of a different study of neuronal development that is currently underway, the pregnant dams had their final weight obtained 36 h prior to euthanasia due to planned injections with 5-bromo-2′-deoxyuridine, which required the transfer of the animals from their usual floor pens to cages. Maximal effort was done to minimize and randomize stress induced by rehousing and to avoid single housing.
Prior to euthanasia at GD45 or GD56, dams were vitCfasted overnight as described above. Prior to anesthesia and cesarean section, dams were injected subcutaneously with Torbugesic Vet 2 ml/kg (Butorphanol 10 mg/ml; ScanVet Animal Health, Fredensborg, Denmark) to induce light sedation and general analgesia in dams and fetuses. Fifteen to 20 min later, animals were deeply anaesthetized by inhalation of 5 % isoflurane (Isoba Vet 100 %, Intervet International, Boxmeer, the Netherlands). Following the disappearance of interdigital and skin reflexes, cesarean section was performed by incision in the linea alba and subsequent exposure of the uterus. The uterus was excised antimesometrial, and fetuses were removed in the same order for every dam beginning from the apex of the left uterine horn (if any pups present) followed by incision in the apex of the right uterine horn. Before removal, the umbilical cord was clamped at the fetal as well as on the placental side to reduced blood loss. Weight and sex were recorded for all viable pups (Table 1 ). In one CTRL45 dam and two DEF45 dams, signs of placentation with small (<3 cm) and indistinct fetal/placental remnants were found in a one fetus of each litter. No adherent signs of inflammation or other macroscopic changes were recorded, and the fetuses were subsequently recorded as degenerated. The remaining pups Table 1 Numbers of guinea pig dams and pups and associated weight recordings and plasma and placental biochemical measurements Data are presented as mean ± SD except from n values. Data from male and female fetuses are pooled because no difference in total plasma ascorbate concentration is observed between sexes NS not significant. Different superscript letters indicate that groups are significantly different * Fetal brain total ascorbate has been reproduced from Paidi et al. [10] Gestational day (GD) 45 from all groups were viable as defined by having a beating heart at time of cardiac puncture. No macroscopic signs of vitC deficiency were observed at either GD45 or GD56. Pups were weighed immediately after removal within less than a minute, and blood was collected by cardiac puncture with an 23-g needle in a 1-ml syringe previously flushed with 15 % tripotassium EDTA [44] . Immediately hereafter, pups were euthanized by decapitation. If any reflexes were present in the pup before or during blood sampling, euthanasia by intraperitoneal injection of 0.5 ml pentobarbital supplemented with lidocaine (200 mg/ml) (Veterinary Pharmacy, University of Copenhagen, Denmark) was performed. After decapitation, the brain was carefully removed and weighed.
Placentas were manually removed where the sub-placenta coalesced with the junctional zone and dispersed in ice-cold PBS to removed excess blood. Residues of the umbilical cord and the yolk sac were cut off prior to weighing and dividing of the placenta for subsequent analyses.
Following removal of the entire litter and while still under deep anesthesia, thoracotomy was performed on the dam and an intracardial blood sample (K 3 -EDTA-flushed 18-g needle and 5-ml syringe) was obtained. Subsequently, dams were euthanized by exsanguination followed by decapitation. Plasma and tissue samples from dams and fetuses were immediately stored at −80 °C until further analysis.
Biochemical analysis
Meta-phosphoric acid-stabilized plasma and placental homogenate were used for analysis of ascorbate and dehydroascorbic acid (DHA) by HPLC with coulometric detection as described previously [45, 46] . Ascorbate oxidation ratio (AOR) in placental tissue was calculated as the fraction of DHA of total vitC (ascorbate and DHA) [47] . Glutathione (GSH) was measured as previously described by Hissin and Hill [48] .
Gene expression analysis (SVCT1 and SVCT2)
Approximately 50 mg tissue of the placentas (from both GD45 and GD56), stored at −80 °C, was weighed for RNA isolation and gene expression analysis. Isolation of RNA and reverse transcription were performed as previously described [35] . Samples were processed for realtime quantitative (RT-qPCR) as previously described [35] . All cDNA samples were tested for DNA contamination by conventional polymerase chain reaction (PCR) before submitting to real-time quantitative PCR (RT-qPCR) using an intron-spanning β-ACTIN primer set [35] . No samples displayed DNA contamination; hence, all were included in the Q-PCR analysis [35, 49] . Q-PCR analysis was performed in triplicates in white 96-well plates on a LightCycler LC480 with LightCycler 480 SYBR Green 1 Master (all from Roche, Basel, Switzerland). Standard curves were created for individual primer sets on calibrator dilutions, and the coherent efficiencies applied in the later expression analysis. Negative controls (nuclease-free water) and calibrator samples were included in all runs. Expression ratios of the two target genes SVCT1 and SVCT2 were acquired by normalization to reference genes β-ACTIN and GAPDH.
Statistical analysis
Effect of dietary regime on overall maternal weight gain during the study was assessed by repeated measurements ANOVA. The effect of vitC intake and GD on maternal 'net weight gain'(i.e., the weight of fetuses and placentas subtracted from the total maternal weight gain), fetal and placental weight recordings, biochemical data and 'fetal vitC availability' were analyzed by two-way ANOVA followed by Bonferroni's post hoc test in case of significance. In case of significant interaction, the two gestational time points were analyzed separately by Student's t test following the F test for equal variance. At the two gestational stages GD45 and GD56, multiple linear regression analysis was applied to further explore any association between the dependent variable, fetal body weight and the fixed explanatory variables, maternal vitC deficiency (CTRL or DEF), the dam's initial weight, size of the litter and sex of the pup. Due to the low number of dams, each pup was analyzed individually. At GD45, appropriate correlation coefficients were computed to assess the relationship between fetal body weight and fetal brain weight or placental weight. A p value <0.05 was considered statistically significant. All analyses were carried out in GraphPad Prism version 5 (GraphPad Software Inc, La Jolla, CA).
Results
Effects of vitC deficiency on dams
Plasma vitC concentrations of the dams were recorded upon arrival and then every second week throughout the study period. In agreement with our previous study in pregnant guinea pigs [6] , no significant difference was found between groups at arrival, but the dietary vitC regimen was reflected in the subsequent blood samples. Thus in DEF animals, plasma vitC decreased significantly within 2 weeks and stayed at a low but non-scorbutic level throughout the study (p < 0.0001; Table 1 ). No signs of pregnancyor vitC deficiency-associated diseases were recorded for any of the dams. Accordingly, no significant difference between groups in overall weight gain was found by 1 3 ANOVA (Fig. 1) . However, to estimate the maternal net weight gain during gestation, the difference between the initial weight of the dams (obtained at GD 6-10) and their final weights 36 h prior to euthanasia was computed. The weights were individually adjusted for the respective cumulated weight of fetuses and placentas to exclude confounding results from differences in litter size and weight of the fetuses. Two-way ANOVA analysis using GD and diet as factors showed an effect of diet (p < 0.05; Table 1 ). Post hoc comparison revealed that maternal weight gain was significantly reduced at GD56 in the deficient group compared with controls (p = 0.0231). As expected, vitC deficiency did not influence mean initial weight of the dam or mean litter size between groups (Table 1) .
Fetal consequences of maternal vitC status At GD45, there was a significant difference in fetal body weight in DEF compared with CTRL (p < 0.05; Table 1 ), while at GD56, no significant difference was observed between groups. Within litters, male DEF pups were significantly heavier than female DEF pups (p < 0.05). To clarify if other variables affected the observed difference, a multiple regression analysis was performed. This showed that fetal body weight at GD45 can be predicted from maternal vitC intake (p < 0.0001), litter size (p < 0.0001) and the initial weight of the dam (p < 0.0001), while sex is not a predictor. According to the model, only litter size influenced fetal body weight (p < 0.005) at GD56 in this study. The overall goodness of the fits were R 2 = 0.8551 (p < 0.0001) and R 2 = 0.2851 (p < 0.05) for GD45 and GD56, respectively. As fetal brain weight is strongly correlated with fetal body weight, the fetal brain weight was, as expected, significantly reduced in the deficient group compared with control at GD45 (p < 0.001; Table 1 ), while this difference was not found at GD56. To separate the effect of maternal vitC deficiency on fetal brain weight from a generalized effect of the fetuses being smaller, the brain weight was adjusted to bodyweight (brain/body (B/B) ratio = brain weight/body weight). Interestingly, the deficient pups had a significantly higher B/B ratio than their control counterparts (p < 0.005) at GD45 suggesting that the brain continues to expand even when overall growth is arrested.
As expected from the maternal dietary regime, mean plasma concentrations of vitC were significantly reduced in DEF pups compared to CTRL counterparts at both GD45 and GD56 (p < 0.0001; Table 1 ). In the CTRL group, a significant decline in mean plasma vitC levels was found from GD45 to GD56 (p < 0.0001; Table 1 ), while this was not the case in the DEF group. At GD45, both groups of pups displayed significantly higher mean plasma levels of vitC compared with their mother (p < 0.0001; CTRL, p < 0.001; DEF), while this was not observed at GD56. However, the CTRL group displayed 10-to 15-fold higher levels of the vitamin compared with the DEF group at both gestational stages and maintained a significant higher mean ratio of maternal plasma vitC concentration compared with pup plasma vitC concentration toward the end of gestation (CTRL ratio 1:1.9 vs. DEF ratio 1:1.3 at GD56, p < 0.05). There was no difference in plasma vitC between males and females within the groups (data not shown), and consequently, male and female data were pooled in subsequent analyses. VitC levels in the fetal brain have been published previously, but are included in Table 1 [10] .
Effects of vitC deficiency on placenta
At both gestational stages, fetal body weight was positively correlated with the weight of the corresponding placenta (or vice versa) ( Table 2 ) and placental weight was significantly reduced in the DEF group compared with CTRL at GD45 (p <0.05; Table 1 ). VitC content in placenta was consistently higher in CTRL groups compared with DEF at both GD45 and GD56 (p < 0.0001; Table 1 ). However, a ~30 % decrease was observed in the CTRL group over time, whereas vitC levels in DEF placentas remained low. To illustrate the placental vitC availability, we corrected for fetal weight and found the placental vitC pool to be largest in CTRL animals (p < 0.0001) and decreased in both groups from GD45 to GD56 (p < 0.001; Fig. 2 ). AOR and GSH were measured to address potential changes in placental redox status, and both markers were increased in the Fig. 1 Maternal weight gain during gestation. Maternal weight is recorded weekly, and there is no difference in overall weight gain by repeated measures ANOVA. When corrected for the weight of placentas and fetuses, the vitC-deficient dams had a significant reduced weight gain compared with controls; however, this estimate might be flawed by unrecorded differences in, i.e., weights of amniotic membranes and fluids and the uterus. n = 17 up to GD44 and subsequently n = 9. GD are approximations ±2 days. The dotted line illustrates zero weight gain. Data are presented as mean ± SEM DEF group at both time points indicating increased vitC turnover and modulation of redox balance (p < 0.0001; Table 1 ). GD also influenced AOR and GSH suggesting an age-dependent difference in susceptibility (p < 0.001; Table 1 ). Finally, to address placental regulation of vitC transport, mRNA expression of SVCT1 and SVCT2 was measured. Q-PCR analysis revealed no detectable difference in placental SVCT1 and SVCT2 between dietary groups; however, a reduction in both was seen on GD56 (p < 0.05) (data not shown).
Discussion
The present study shows that prolonged maternal vitC deficiency during pregnancy in guinea pigs results in a transient intrauterine growth retardation of the fetuses and their corresponding placentas at GD45. These effects were normalized by day 56 of gestation, which suggests that the growing fetus displays an increased sensitivity toward maternal vitC deficiency during this time of gestation. Moreover, maternal deficiency has a significant impact on placental and fetal vitC concentration throughout gestation. Accordingly, the fetal 'availability' of vitC measured as placental pool per fetal weight is reduced in DEF animals compared with CTRL and the increase in AOR and GSH in DEF placentas may suggest an adaptive response in redox status, which may further decrease the degree of vitC availability and thus negatively affect placental function.
Intrauterine growth restriction (IUGR) in humans is associated with increased risk of adverse pregnancy outcome [50] [51] [52] and perinatal complications related to the brain, e.g., intracranial hemorrhages [50, 53] . Moreover, IUGR has also been suggested to alter fetal epigenetic programming leading to long-term neurodevelopmental implications [50, 54] and possibly chronic disease later in life [55] . In the present study, prenatal vitC deficiency caused a 22 % reduction in fetal body weight compared with fetuses from vitC sufficient control mothers at GD45. An isolated effect of vitC as causal factor was supported by the multiple regression analysis. As reported for humans, we found in guinea pigs that fetal birth weight is correlated with the mother's initially recorded weight in early pregnancy [56] and that fetal growth rate is negatively affected by increased number of siblings [57] , while sex is not a predictor of fetal weight. No differences between mean initial maternal weight recordings or mean litter sizes were found between CTRL and DEF groups (Table 1 ). This strongly suggests that the fetal growth retardation at GD45 in the DEF group is independently caused by the dietary induced maternal vitC deficiency. VitC has been reported to be an independent factor in determining both placental weight and birth weight in human infants born to term [28, 58] . Though authors do not disclose a beneficial action of vitC supplementation, the reported association may suggest a role of vitC in placentation and fetal growth. Furthermore, a randomized, controlled trial of vitC supplementation in preterm infants showed a tendency to improve clinical outcome in subjects exposed to high vitC compared with lower counterparts though a small group size reduces the overall power of the findings [59] .
In humans, as in this study, placental and fetal weights are highly correlated [56] (Table 2) . Accordingly, the GD45 placentas of the DEF fetuses displayed a 15 % weight reduction compared with CTRLs. As this study did not include earlier gestational stages, the precise etiology of the observed growth retardation, i.e., if placental growth retardation causes fetal growth retardation or vice versa, cannot be determined. It has previously been described that the vitC-deficient guinea pig dams at GD35 show atrophy of uterine villi compared with controls, while no effect on Putative fetal vitC availability expressed by total placental vitC content (nmol) divided by fetal body weight (g) is significantly higher in CTRL compared with DEF animals at both GD45 and GD56 (***p < 0.001). Moreover, the vitC availability decreased significantly in both groups from GD45 to GD56 (***p < 0.001). Data are presented as mean ± SD fetal weight could be detected [60] . Although authors did not report placental weights or presented a quantitation of the described length reduction in the endometrial villi, the observed atrophy supports the hypothesis that vitC deficiency leads to primary placental growth retardation at this stage of gestation. Accordingly, in vitro studies have shown that vitC inhibits apoptosis of placental trophoblast cells and increases differentiation into syncytiotrophoblast, the site of materno-fetal nutritional exchange [61] . Thus, our results of a transient growth retardation of vitC-deficient placentas and fetuses-which is subsequently compensated toward the end of pregnancy-are in agreement with reports stating that during placentation, sufficient vitC is required for proper tissue differentiation and development and thus for embryogenesis [62, 63] , while it may be less important for growth later in fetal life. This is supported by weight recordings from naturally delivered guinea pigs showing no effect of maternal subclinical vitC deficiency on birth weight [6, 64] . We hypothesized that the ability to regain placental and fetal bodyweight in late gestation at least partially may be caused by a compensatory up-regulation (or absent downregulation) of the placental vitC transporters. The regulation of placental-fetal transfer of vitC is most likely controlled by SVCT2, which has been also been reported to dominate placental transport of vitC in humans [27, 65, 66] over SVCT1 [26, 27] . SVCT2 expression in human term placenta is not consistently present between studies [27, 66] suggesting decreased expression at the last part of gestation/close to parturition. This theory is compatible with the decreasing maternal and fetal plasma levels of vitC toward the end of pregnancy in both guinea pigs and humans [6, [67] [68] [69] [70] and is supported by our results showing a decreased expression of the SVCTs at GD56. We therefore consider the decline in vitC levels in CTRL animals at approaching term as part of normal gestation, possibly due to a reduced requirement at this developmental stage. However, whereas CTRL animals are able to display a decrease in vitC at GD56, DEF are not. This is likely due to the lack of adequate levels at GD45, not allowing for fluctuations in vitC levels. In the present study, placental vitC concentration was sustained in DEF placentas from GD45 to GD56 (Table 1) suggesting that vitC transport to the fetus is maintained despite maternal deficiency. However, the estimated fetal vitC availability (measured as total placenta vitC content/fetal body weight) decreased with 50 % within the same period in DEF groups (Fig. 2) , indicating that placental transport is indeed adjusted according to gestational age, although this may not benefit the fetus. However, as no significant change effect in the expression of SVCT1 or SVCT2 could be detected between the dietary groups, the induced degree of deficiency did not induce an up-regulation of transcriptional vitC transporters in the present study.
Whether a post-translational regulation exits to manage the feto-maternal tug-of-war for vitC remains to be assessed.
In humans, low levels of vitC have been associated with oxidative stress in neonates [71] and placental oxidative stress is thought to be included in the etiology of, e.g., preeclampsia and miscarriages [72] . Currently the majority of data from the human clinic do not show a direct effect of vitC supplementation in the prevention of preeclampsia (recently reviewed by Conde-Agudelo et al. [32] and Salles et al. [32, 33] ). However, a significant obstacle in the interpretation of the published data in this field is the lack of maternal vitC level as inclusion criterion [32, 73] . As supplementation of subjects already receiving sufficient amounts of vitC is redundant, determination of deficient subgroups eligible for intervention is pivotal to the evaluation of putative effects of vitC. Furthermore, the majority of human studies include treatment with vitC and vitE (and other micronutrients) in combination rendering evaluation of specific effects of vitC difficult at best. In this study, DEF placentas displayed a significant increase in AOR and GSH concentrations at both GD45 and GD56 compared with CTRLs, despite a similar pattern of age-dependent expression of the markers. Both markers indicate an increased oxidation of ascorbate, likely due to increased levels of reactive oxygen species (ROS) and promoting redox imbalance. VitC has also been associated with the synthesis of placental steroids and polypeptide hormones [27, 74] , crucial for normal fetal development and maintenance of pregnancy [75] . Moreover, an impairment of vitC-dependent cofactors may affect specific reactions such as the assembly of collagen triple helixes to form mature and functional collagen and/or decrease hydroxylation of hypoxia inducible-transcription factors (HIFs) disrupting vascular integrity and fetal growth [76] [77] [78] [79] .
Hence, it is plausible that vitC exerts its effects in both placenta and fetus via multiple pathways, supported by findings of an association between severe maternal vitC deficiency and reduced body and organ weight, as well as fatal developmental abnormalities in multiple organ systems in animal models (both mice, rats and pigs) incapable of vitC synthesis or transport [8, 60, [80] [81] [82] . Investigations of oxidative stress markers in animals from the current study have revealed a vitC deficiency-imposed increase in lipid peroxidation and in SOD in the brain at GD56 compared with sufficient counterparts [10] . This suggests that the re-establishment of growth parameters by the end of term does not out-balance brain oxidative stress, placing this organ at risk of damage. This is in line with vitCdeficient guinea pig pups displaying decreased hippocampal volume after birth persisting at least until 2 months of age and irrespective of postnatal repletion [9] . The growth retardation at GD45 points toward this time point as being of increased sensitivity to vitC deficiency, coalescing with the peak of the 'brain growth spurt' [83, 84] . Although the growth retardation appears transient when general weight parameters are reviewed, irreversible effects, e.g., on regional brain development and maturation require further investigation.
As previously reported in humans and guinea pigs [64, 69, 85, 86] , maternal plasma concentrations of vitC were reflected in fetal levels of the vitamin in this study. In line with vitC recordings in the placenta and brain [10] , a significant effect of GD was found in plasma of CTRL fetuses, while in DEF, vitC concentrations were sustained at a constant low level with tenfold reduced intrauterine plasma vitC levels at GD45 and 15-fold at GD56 compared with CTRL groups-a difference that is likely to increase to 50-fold postnatally [6] . At GD45, fetal levels of vitC were higher than maternal in both groups, while the difference was not significant at GD56. However, when computing the mean fetal/mean maternal vitC ratio, CTRL pups were capable of maintaining a high ratio (1:3.2 at GD45 vs. 1:1.9 at GD56), while DEF pups displayed a significantly lower ratio toward end of pregnancy (1:3.8 at GD45 vs. 1:1.3 at GD56). This supports our hypothesis that preferential materno-fetal vitC transport is overridden during prolonged maternal vitC deficiency, protecting the mother from severe vitC deficiency at the expense of the fetus [6] . However, the adjusted weight gain of the DEF dams was significantly reduced toward end of pregnancy indicating a negative response to the imposed vitC deficiency.
Though the reported findings suggest vitC as an important factor particularly during specific stages in fetal development, the current study has some limitations. The number of included dams is relatively small (n = 4-5), thus limiting our ability to sufficiently assess potential differences at the dam level. The included number of dams was aimed at obtaining a sufficient number of pups based on previous experiments [6] . With regard to assessing maternal vitC status, we have previously established that this is normally distributed in the guinea pig population. However, future investigations should include more dams to control for effects associated with the individual dam. It is also possible that vitC deficiency might affect maternal feed intake, hereby reducing weight gain and adding further insult to the nutritional balance in dams and fetuses. Should this be the case, a reduced nutritional status may propagate cellular stress and redox imbalance leading to exacerbate the observed effects of vitC deficiency. Due to group housing in large floor pens according to animal welfare legislation, it was not possible to accurately measure feed intake. Consequently, a potential effect of vitC deficiency on feed intake cannot be addressed or ruled out and is therefore purely speculative.
In conclusion, in guinea pigs, prolonged maternal vitC deficiency during gestation results in a transient retardation of fetal and placental growth prior to the last third of pregnancy. The present data, combined with our previous reported in vivo results [6, 9] , suggest that vitC plays a critical role in fetal development. These results demonstrate that maternal deficiency is transferred to the fetus, which is not protected by a preferential placental transport but rather subjected to redox imbalance. Based on the results of this and our previous studies, we speculate that inadequate maternal vitC intake may lead to placental deficiency and reduced fetal nutrition causing abnormal development.
